February 26, 2020 / 11:05 PM / a month ago

BRIEF-Editas Medicine Reports Q4 Loss Per Share $0.74

Feb 26 (Reuters) - Editas Medicine Inc:

* EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS AND UPDATE

* Q4 LOSS PER SHARE $0.74

* Q4 EARNINGS PER SHARE ESTIMATE $-0.10 — REFINITIV IBES DATA

* ANNOUNCEMENT OF FIRST PATIENT DOSING WITH EDIT-101 (AGN-151587) EXPECTED IN 1Q20

* PLAN TO FILE IND FOR EDIT-301 FOR SICKLE CELL DISEASE BY END OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below